The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term survival in 101 metastatic gastroesophageal cancer (mGEAC) patients eventually treated with consolidative local therapy.
 
Dilsa Mizrak Kaya
No Relationships to Disclose
 
Xuemei Wang
No Relationships to Disclose
 
Kazuto Harada
No Relationships to Disclose
 
Mariela A. Blum Murphy
Honoraria - EMD Serono
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst)
 
Prajnan Das
Honoraria - Potomac Center for Medical Education
 
Bruce D. Minsky
Other Relationship - American Society for Radiation Oncology; MD Anderson Physician’s Network
 
Jeannelyn Estrella
No Relationships to Disclose
 
Quan Lin
No Relationships to Disclose
 
Fatemeh Ghazanfari Amlashi
No Relationships to Disclose
 
Jeffrey H Lee
No Relationships to Disclose
 
Brian Weston
No Relationships to Disclose
 
Manoop S. Bhutani
No Relationships to Disclose
 
Aurelio Matamoros
No Relationships to Disclose
 
Tara L. Sagebiel
No Relationships to Disclose
 
Heath Devin Skinner
No Relationships to Disclose
 
Carol C Wu
No Relationships to Disclose
 
Wayne Lewis Hofstetter
No Relationships to Disclose
 
Brian D. Badgwell
No Relationships to Disclose
 
Jaffer A. Ajani
Honoraria - Bayer; Five Prime Therapeutics; Genentech; Lilly/ImClone; Novartis; Roche/Genentech; Taiho Pharmaceutical
Research Funding - Amgen; Bristol-Myers Squibb; Delta-Fly Pharma; Gilead Sciences; Lilly/ImClone; MedImmune; Merck; Novartis; Roche/Genentech; Taiho Pharmaceutical; Takeda
Patents, Royalties, Other Intellectual Property - I have research funding from: Genentech, Roche, BMS, Taiho, MedImmune, Merck, Amgen, Lilly
Travel, Accommodations, Expenses - Bayer; Five Prime Therapeutics; Novartis